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Abstract
The repair of large cartilage defects with hyaline cartilage continues to be a challenging clinical issue. We recently reported
that the forced expression of two reprogramming factors (c-Myc and Klf4) and one chondrogenic factor (SOX9) can induce
chondrogenic cells from mouse dermal fibroblast culture without going through a pluripotent state. We here generated
induced chondrogenic (iChon) cells from human dermal fibroblast (HDF) culture with the same factors. We developed a
chondrocyte-specific COL11A2 promoter/enhancer lentiviral reporter vector to select iChon cells. The human iChon cells
expressed marker genes for chondrocytes but not fibroblasts, and were derived from non-chondrogenic COL11A2-negative
cells. The human iChon cells formed cartilage but not tumors in nude mice. This approach could lead to the preparation of
cartilage directly from skin in human, without going through pluripotent stem cells.
Citation: Outani H, Okada M, Yamashita A, Nakagawa K, Yoshikawa H, et al. (2013) Direct Induction of Chondrogenic Cells from Human Dermal Fibroblast Culture
by Defined Factors. PLoS ONE 8(10): e77365. doi:10.1371/journal.pone.0077365
Editor: Dimas Tadeu Covas, University of Sao Paulo - USP, Brazil
Received February 20, 2013; Accepted September 2, 2013; Published October 16, 2013
Copyright:  2013 Outani et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by Scientific Research Grants Nos. 18390415, 19659378 and 21390421 from MEXT and the JST, CREST. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ntsumaki@cira.kyoto-u.ac.jp
Introduction
Articular cartilage provides shock absorption and lubrication in
diarthrodial joints. Articular cartilage is a hyaline cartilage which
consists of chondrocytes and cartilage extracellular matrix
composed of types II, IX and XI collagen molecules, proteogly-
cans, and other matrix proteins. Because hyaline cartilage has a
poor intrinsic capacity for healing, the loss of cartilage due to
trauma or degeneration caused by aging can result in debilitating
conditions and osteoarthritis.
Cartilage damage sometimes heals with fibrocartilage, which
differs from hyaline cartilage. Fibrocartilage is a type of scar tissue
that expresses types I and II collagen; hyaline cartilage, in contrast,
does not express type I collagen [1,2]. As the presence of type I
collagen impairs the development of cartilage-specific matrix
architecture and mechanical function, the repair of cartilage
damage by fibrocartilage results in morbidity and functional
impairment. Therefore, the goal for repair of cartilage injury is the
regeneration of organized hyaline cartilage, rather than healing
with fibrocartilage [3]. Although autologous chondrocyte implan-
tation has been successfully performed, the indications are limited
to a small size defect, because chondrocytes are limited in number,
and because they de-differentiate into fibrochondrocytes during
monolayer expansion in culture [4]. Defects larger than 4 cm2 in
size cannot be repaired because of the lack of a sufficient number
of bona fide chondrocytes to fill the defect.
Sox9, Sox5 and Sox6 play important roles in the commitment
of mesenchymal cells to the chondrocyte lineage. In mouse
chimeras, Sox92/2 cells are excluded from the cartilage primordia
throughout embryonic development [5,6]. Sox9, Sox5, and Sox6
activate the transcription of chondrocyte-marker genes by binding
their enhancers [7–10]. It was reported that the forced expression
of Sox5, Sox6 and Sox9 by adenoviral vectors in dermal
fibroblasts causes the expression of their target gene, type II
collagen [11]. However, the histology of pellet cultures of these
cells appears to be fibrocartilaginous, suggesting that the
fibroblastic characteristics of the cells persist. Therefore, the cells
produced in that study may correspond to fibrocartilaginous cells,
rather than hyaline cartilaginous cells. Although dermal fibroblasts
represent a readily accessible cell source, their tendency for high
expression of type I collagen is a large obstacle to the production of
hyaline cartilage. To eliminate the fibroblastic characteristics of
these cells, a cell reprogramming process may be necessary.
A large number of autologous hyaline chondrogenic cells may
be obtained by generating iPS cells, followed by redifferentiation
into a chondrocytic lineage in the future. However, transplanta-
tion of redifferentiated chondrocytes is associated with a risk of
teratoma formation due to the possible presence of residual
undifferentiated cells. Recently, we induced chondrogenic cells
directly from adult mouse dermal fibroblast (MDF) culture by
transduction of two reprogramming factors (c-Myc, Klf4) and
SOX9 [12]. The induced chondrogenic cells formed histologically
homogenous hyaline cartilage when injected into the subcutaneous
spaces of nude mice. Time-lapse observations of MDF cultures
prepared from Nanog-GFP transgenic mice [13] revealed that
GFP was not expressed during the induction of chondrogenic cells
by transduction of c-Myc, Klf4, and SOX9, proving that the cells
do not transition through a pluripotent state during the direct
induction of chondrogenic cells from MDFs [14]. Therefore, the
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induced chondrogenic cells produced by this method are
theoretically free from the risk of teratoma formation.
Future clinical application of this technique of regenerative
medicine for articular cartilage diseases will require confirmation
that chondrogenic cells can be directly induced from human
dermal fibroblast culture. We here generated induced chondro-
genic (iChon) cells from human dermal fibroblast (HDF) cultures.
We employed nucleofection to misexpress Slc7a1, a receptor for
retrovirus, followed by retroviral transduction of the same three
factors, to cause the transformation of human dermal fibroblasts
into chondrogenic lineage cells. We also developed a chondrocyte-
specific COL11A2 promoter/enhancer lentiviral reporter vector, to
select human iChon cells. The human iChon cells expressed type
II collagen, but not type I collagen. These human iChon cells
generated stable homogenous hyaline cartilage-like tissue without




All experiments were approved by our institutional animal
committees, institutional biosafety committees, and institutional
review boards of Osaka University and Kyoto University.
Lentiviral Vectors and Transduction
The pLenti6/UbC/mSlc7a1 (Addgene plasmid 17224) was a
gift from S. Yamanaka (Center for iPS Cell Research and
Application (CiRA), Kyoto University, Kyoto, Japan) [15].
For construction of chondrocyte-specific reporter vectors, the
human sequences corresponding to the mouse Col11a2 promoter
and enhancer [16] were amplified by PCR. The human COL11A2
enhancer was linked to the EGFP-IRES-Puro sequence in the
pENTR59 plasmid (Invitrogen) [12] to prepare pENTR1A-mcs/
(EGFP-IresPuro-hInt) (P4-40). The human COL11A2 promoter
was cloned into the pENTR59 plasmid (Invitrogen) to prepare
pENTR59-mcs/11P (P4-41). The lentiviral vector, pLe6D (P4-32)
was prepared by deleting the PGKpromoter-EM7-Blastcidine
sequence at KpnI sites from pLenti6.4/R4R2/V5-DEST (Invitro-
gen). pENTR1A-mcs/(EGFP-IresPuro-hInt) (P4-40) was recom-
bined with pENTR59-mcs/11P (P4-41) and pLe6D by the LR
clonase II plus reaction (Invitrogen) to prepare pLe6D -hLP-mcs/
(EGFP-IresPuro-hInt) (P4-42, COL11a2-reporter vector), respec-
tively. Lentiviral transduction was performed following the
manufacturer’s instructions (Invitrogen).
Cell Culture
Human dermal fibroblasts (HDFs) prepared from neonatal
foreskin were purchased from Kurabo (KF-4009). On arrival, the
HDFs were thawed, and 56105 cell were plated in a 10 cm dish in
DMEM supplemented with 10% FBS. The next day, the cells
were either untransduced, or were transduced with lentiviral
COL11A2-reporter vectors overnight. The cells were subsequently
split 1:5 into 10 cm dishes and stored in liquid nitrogen until use.
Human chondrosarcoma (HCS-2/8) cells were cultured in
DMEM supplemented with 10% FBS [17].
Chondrogenically Differentiated Human Bone Marrow
Stem Cells
Human bone marrow stem cells (hBMSC) were purchased from
Takara (PT-2501). On arrival of frozen stock of hBMSC, the cells
were thawed and 36105 cell were plated in a 10 cm dish in
aMEM supplemented with 10% FBS. When the cells became
confluent, the culture was passaged (P1). Expanded hBMSC (P2)
were suspended at 36105 cells/ml in aMEM containing 10%
FBS, transferred into a 15-ml tube (Falcon), and centrifuged at
500 g for 5 min. The resulting cell pellet was incubated in a
chondrogenic differentiation medium (purchased from Takara
[PT-3003, PT-4124]) for 3 weeks, and the resulting cells were
called chondrogenically differentiated human bone marrow stem
cells (CD-hBMSC).
Nucleofection of Slc7a1
The Slc7a1 sequence from pLenti6/UbC/mSlc7a1 (Addgene
plasmid 17224) was cloned into pDONR221 (Invitrogen) by BP
clonase (Invitrogen) to prepare pDONR221-mSlc7a1 (P8-63).
pDONR221-mSlc7a1 (P8-63) was recombined with pCMVb-gw
(P1-32) by the LR reaction (Invitrogen) to prepare pCMV-gw/
mSlc7a1 (P9-75). pCMV-gw/mSlc7a1 (P9-75) was introduced into
HDFs using nucleofection technology following the manufactur-
er’s instructions (Amaxa).
Retroviral Vectors and Transduction
pMXs-c-MYC (Addgene plasmid 17220) and pMXs-KLF4
(Addgene plasmid 17219), were gifts from S. Yamanaka (Center
for iPS Cell Research and Application (CiRA), Kyoto University,
Kyoto, Japan) [15]. pMXs-hSOX9 was described previously [12].
Human SOX5 and SOX6 cDNAs were PCR amplified using
specific primers (Table S3) and were cloned into pDONR222
vector (Invitrogen) to create pENTR-hSOX5 (P5-41) and
pENTR-hSOX6 (P5-42). pENTR-hSOX5 (P5-41) or pENTR-
hSOX6 (P5-42) were recombined with pMXs-gw by the LR
reaction (Invitrogen) to prepare pMXs-gw/hSOX5 (P8-83) or
pMXs-gw/hSOX5 (P8-84). A sequencing analysis showed the
hSOX5 and hSOX6 sequences to be correct.
Retroviral transduction was performed as described previously
[18]. The Plat-E cells were a gift from T. Kitamura (The Institute
of Medical Science, The University of Tokyo, Tokyo, Japan) [19].
Equal amounts of supernatants containing each of the
retroviruses were mixed and added to the HDF cultures. After a
16-h incubation in the virus-containing medium, each fibroblast
culture in the 10 cm dishes was trypsinized and split 1:5 into new
10 cm dishes in fresh medium (DMEM supplemented with 10%
FBS). The medium was changed every other day. In the cultures
transduced with lentiviral COL11A2-reporter vectors, puromycin
was added to the medium when GFP fluorescence was detected in
some cells at around 7 days after retroviral transduction. At 21
days after retroviral transduction, dishes were subjected to alcian
blue staining. The colony numbers were counted using the NIS
Element software program (Nikon). We defined a colony as a cell
cluster that was more than 0.5 mm in diameter. Other dishes were
used for picking up colonies to generate induced chondrogenic
cells.
Alcian Blue Staining
Cells were fixed with methanol at 220uC for 2 min, incubated
with 0.1% alcian blue (Sigma) in 0.1 N HCl for 2 h at 25uC, and
washed three times with distilled water.
Generation of Induced Chondrogenic Cell Lines
After setting up a sterile cylinder surrounding each colony, we
harvested the cells by trypsinization, and replated them in 48 well
dishes. After 6–10 days, the cells were replated in 24 well dishes.
Then, cells were replated successively into 12 well, 6 well, 6 cm,
and 10 cm dishes after culturing for them 3–14 days in each dish.
We defined the stage of cells in 10 cm dishes as passage 6. The
induced chondrogenic cells were cultured in DMEM containing
Induced Chondrogenic Cells from Human Fibroblasts
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10% FBS in the presence of 1 mg/ml puromycin. Induced
chondrogenic cells were passaged every 6 days. We initiated the
growth curve analyses of induced chondrogenic cells at passage 11.
Genomic PCR Analysis
The iChon cells (passage 11) and HDFs (passage 3) were
cultured in 60 mm dishes. After the cells reached confluence, the
genomic DNA was extracted and subjected to PCR to amplify
transgenes. For the control, a fragment of the GAPDH gene was
amplified. The primers used are listed in Table S2.
RT-PCR and Real-time RT-PCR Analyses
After the iChon cells and HDFs cultured in 60 mm dishes
reached confluence, the total RNA was extracted using RNeasy
Mini Kits (Qiagen). The total RNAs prepared from the
redifferentiated human fetal chondrocytes (HFC) were purchased
from Cell Applications, Inc. (402RD-R10f). The total RNA was
extracted from CD-hBMSCs. The total RNAs were digested with
DNase to eliminate any contaminating genomic DNA. For RT-
PCR analysis, 1 mg of total RNA was reverse transcribed into first-
strand cDNA by using Superscript III Reverse Transcription
(Invitrogen). PCR was performed with ExTaq (Takara). The
primers used are listed in Tables S2 and S3. For real-time
quantitative RT-PCR, 1 mg of total RNA was reverse transcribed
into first-strand cDNA by using SuperScript III (Invitrogen) and
an oligo(dT)20 primer. The PCR amplification occurred in a
reaction volume of 20 ml containing 2 ml of cDNA, 10 ml of
SYBER PremixExTaq (Takara) and 7900HT (Applied Biosys-
tems). The PCR primers used are listed in Table S3. The RNA
expression levels were normalized to the level of GAPDH
expression.
Determination of Karyotypes
iChon cells were subjected to karyotype analyses at Nihon Gene
Laboratories (Japan).
Immunofluorescence Staining
The cells were cultured on culture slides, fixed in 4%
paraformaldehyde and permeabilized with 0.5% Tween 20. The
cells were then incubated with the primary antibodies listed in
Supplemental Table S4. Immune complexes were detected by
using the appropriate secondary antibodies conjugated to Alexa
Fluor (Table S4).
Bisulfite Genomic Sequencing
Bisulfite treatment was performed by using the EpiTect Bisulfite
kit (Qiagen) according to the manufacturer’s instructions. The
PCR primers used are listed in Table S3. Amplified products were
cloned into the pMD20-T vector using a Mighty TA-cloning Kit
(Takara). Twelve randomly selected clones were sequenced with
the M13 primer, RV, and M13 primer, M4, for each gene.
Pellet Culture
Induced cells were suspended at 56105 cells/ml in DMEM
containing 10% FBS, transferred into a 15-ml tube (Falcon), and
centrifuged at 500 g for 5 min. The resulting cell pellet was
incubated in chondrogenic medium (DMEM, 10% FBS, TGF-b
10ng/ml, DEX 1027 M, Ascorbic acid 50 mg/ml, Pyrubate
100 mg/ml and ITS 6.25 mg/ml) for 3 weeks.
Picrosirius Red Staining and Immunohistochemical
Staining
Semi-serial histological sections were stained with picrosirius red
using the Picrosisius red stain kit (Plysciences, Inc.) and immuno-
stained with the primary and secondary antibodies listed in Table
S4. For controls, sections from osteochodromas obtained at the
time of surgery were used to test the anti-type I and anti-type II
collagen antibodies.
In vivo Cartilaginous Tissue Formation in Nude Mice
The iChon cells were suspended at 16107 cells/ml in DMEM
containing 10% FBS. Then, 100 ml of the cell suspension was
injected subcutaneously into the dorsal flank of 6-week-old female
nude mice (BALB/cA Jcl-nu/nu). No carrier was used. The mice
were sacrificed after 4, 8, 12 weeks, and the injected sites were
dissected from the mice. Samples were fixed in 10% neutral
buffered formalin, processed, and embedded in paraffin.
Implantation of Human iChon Cells into the Articular
Cartilage Defects in Severe Combined Immunodeficiency
(SCID) Rats
The skin and joint capsule of a knee joint in 6-week-old SCID
rats (F344-Il2rgtm2kyo) [20] were opened. A drill hole with a
diameter of 1 mm was created at the femoral groove. A pellet of
56105 iChon cells was implanted into the hole, then the joint
capsule and skin were closed. The rats were sacrificed four weeks
later.
Culture of iChon Cells Under Osteogenic Conditions
A total of 26105 iChon cells were plated in each well of a six
well plate, and cultured in the osteogenic medium (a-MEM
supplemented with 10% FBS, 10 mM b-glycerophosphate,
50 mg/ml ascorbic acid, and 1027 M Dexamethasone in the
absence or presence of various concentrations of BMP2). The
medium was changed every other day. RNAs were extracted from
the cells after 21 days of culture, and were subjected to a real-time
RT-PCR expression analysis. As control, RNAs were extracted
from subchondral bone samples collected from the tibia and femur
at the time of surgery.
Implantation of iChon Cells into the Calvarial Defects of
SCID Mice
The skin on the head of 5-week-old SCID mice (C.B-17/lcr-
scid/scid Jcl) was incised, then a drill hole with a diameter of
1 mm was created at the calvarium. A pellet of 56105 iChon cells
was implanted into the hole, then the skin was closed. The mice
were sacrificed three weeks later.
Statistical Analysis
The data are shown as averages and standard deviations. Two-
tailed Student’s t-tests were used to compare the data. P values
,0.05 were considered to be statistically significant.
Results
The Generation of Human Induced Chondrogenic (iChon)
Cells from HDFs by Transduction of c-MYC, KLF4 and
SOX9
We first transduced neonatal foreskin HDF cells (Figure 1A,
middle left panel) with lentiviral vectors bearing human c-MYC,
KLF4 and SOX9, but failed to obtain cells with the polygonal
morphology which is typical shape of cultured chondrocytes.
Induced Chondrogenic Cells from Human Fibroblasts
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Therefore, we transduced HDFs with these factors following
another previously described method using Slc7a1 encoding a
receptor for the retrovirus [15]. We tried to increase the titer of
retroviral infection by transducing HDFs with Slc7a1 using
nucleofection technology to increase the expression levels of
Slc7a1. Two days after the nucleofection of Slc7a1, we transduced
the HDFs with retroviral c-MYC, KLF4 and SOX9 vectors. Five
days after retroviral transduction, we detected polygonal cells in
the HDF culture. The polygonal cells (Figure 1A, middle right
panel) formed multiple layers at 14 days after transduction, giving
rise to cell nodules (Figure 1A, bottom left panel) which is a
characteristic of cultured primary chondrocytes [21]. The nodules
were surrounded by cells that had the morphological appearance
of fibroblasts. These nodules were specifically and intensely stained
with alcian blue (Figure 1A, bottom right), suggesting the existence
of acid glycosaminoglycans, which is an element of cartilage
extracellular matrix. The surrounding cells that had the morpho-
logical appearance of fibroblasts were not stained with alcian blue.
These results suggest that forced expression of c-MYC, KLF4 and
SOX9 can produce induced chondrogenic (iChon) cells from
human skin fibroblast cultures.
Selection of Human iChon Cells with a COL11A2
Enhancer-based Lentiviral Reporter Vector
To remove fibroblastic cells and isolate homogenous polygonal-
shaped iChon cell populations, we constructed a chondrocyte-
specific reporter vector using EGFP and puromycin-resistant genes
linked by the IRES sequence on the lentiviral vector. To obtain
chondrocyte-specific expression, we employed promoter and
enhancer sequences of the human a2(XI) collagen chain
(COL11A2) gene (Figure S1A) that correspond to the mouse
Col11a2 promoter and enhancer, which direct chondrocyte-
specific expression [16]. The COL11A2-reporter vector directed
substantial GFP expression in human chondrosarcoma (HCS-2/8)
cells [17] but not in HDFs (Figure S1B). We transduced the HDFs
with lentiviral COL11A2-reporter vectors overnight, split them 1:5,
and made a cell stock from these cells. The cell stock of HDFs
transduced with reporters was thawed (day 0) and we nucleofected
the cells with Slc7a1 (day 2). We then replated 56105 cells in a
10 cm dish (day 3) and transduced the cells with retroviral vectors
bearing c-MYC, KLF4 and SOX9 (day 5) overnight. Immediately
after retroviral transduction, the cells were split 1:5 in 10 cm
dishes (day 6) (Figure 1B). Polygonal-shaped cells, which appeared
5 days after retroviral transduction with c-MYC, KLF4 and
SOX9, started to show COL11A2-GFP fluorescence. Subsequently,
the polygonal-shaped cells formed nodules. EGFP was expressed
in the nodules, but not in the surrounding fibroblastic cells in the
absence of puromycin (Figure 1B). The transduction of 56105
HDFs with c-MYC, KLF4 and SOX9 resulted in the formation of
1200 nodules, which showed intense staining for alcian blue in the
absence of puromycin (Figure 1C) in five 10 cm dishes. Therefore,
the efficiency of the induction of alcian blue-positive cells was
0.24%. On the other hand, the transduction of HDFs with the
control retroviral DsRed fluorescent protein vector resulted in
neither nodule formation nor substantial alcian blue staining
(Figure 1C). Because a combination of SOX9, SOX5 and SOX6
was previously reported to activate the expression of chondrocyte-
markers in HDFs [11], we transduced HDFs with SOX9, SOX5
and SOX6. We confirmed that the SOX5, SOX6 and SOX9
proteins were expressed by immunoblot analyses (Figure S2). We
found neither nodule formation nor any substantial alcian blue
staining in the HDFs transduced with SOX9, SOX5 and SOX6
(Figure 1C). These results indicate that c-MYC and KLF4 play a
critical role in the conversion from fibroblasts to chondrogenic
cells by SOX9.
To isolate colonies, we started to add puromycin to the medium
when GFP fluorescence was detected at 5–7 days after transduc-
tion with c-MYC, KLF4 and SOX9. The majority of fibroblastic
cells and four-fifths of the polygonal-shaped cells died, leaving 267
surviving colonies, on average, in the culture in the presence of
1 mg/ml puromycin (Figure 1D). On average, 186 out of the 267
colonies were intensely stained with alcian blue and were
composed of polygonal cells. The remaining 81 colonies were
large and diffuse, as indicated by crystal violet staining, and were
composed of fibroblastic cells. The transduction of HDFs with the
control retroviral DsRed vector instead of c-MYC, KLF4 and
SOX9 vectors produced 107 colonies in the presence of
puromycin. These colonies were not stained with alcian blue
(Figure 1D), and were composed of fibroblasts. These fibroblasts
survived in the presence of puromycin, probably because of the
aberrant expression of the lentiviral COL11A2-reporter vector.
The transduction of HDFs with SOX9, SOX5 and SOX6 also
produced 91 colonies in the presence of puromycin. These
colonies did not stain for alcian blue (Figure 1D), and were
composed of morphologically fibroblastic cells.
Therefore, the transduction of the lentiviral COL11A2 reporter
vector and selection with puromycin resulted in the formation of
nodules as colonies, 70% of which were composed of polygonal-
shaped cells. The colonies composed of polygonal cells were
almost all intensely stained with alcian blue. We picked up colonies
which were composed of polygonal-shaped cells, and added them
in the wells of 48 well plates and expanded each cell line by
replating them onto successively larger dishes. We established 15
clones which reached subconfluency in 10 cm dishes, and were
subjected to the further analyses.
Characteristics of the iChon Cells
Isolated human iChon cells showed a polygonal morphology
(Figure 2A). We found that all three (c-MYC, KLF4 and SOX9)
transgenes were transduced into the genomic DNA (Figure S3A)
and were expressed (Figure 2B) in iChon cells. These results
suggest that retrovial transgenes were not silenced in iChon cells.
A growth curve analysis showed that the proliferation rates of the
established human iChon cell lines were lower than those of the
parental HDFs (Figure 2C). A karyotype analysis showed that 20
out of 20 cells (iChon 87-18), 20 out of 20 cells (iChon 117-3) and
14 out of 20 cells (iChon 117-37) had normal karyotypes
(Figure 2D and Figure S3B).
A real-time RT-PCR analysis showed that human iChon cells
expressed neither COL1A1 nor COL1A2 mRNAs, which the
parental HDFs expressed abundantly (Figure 3A). With regard to
the control, redifferentiated human fetal chondrocytes (HFC)
expressed both COL1A1 and COL1A2, probably because fibro-
blasts had contaminated the cells during their collection, or
because of dedifferentiation of chondrocytes during culture. On
the other hand, the iChon cells expressed chondrocyte-specific
marker genes, COL2A1 and ACAN, whereas the HDFs did not.
The iChon cell lines showed little expression levels of the
hypertrophic chondrocyte marker COL10A1 and terminally
differentiated chondrocyte markerMMP13 (Figure 3B). Regarding
the control, we prepared chondrogenic cells by differentiation
from human bone marrow stem cells. Chondrogenically differen-
tiated human bone marrow stem cells (CD-hBMSCs) expressed
COL10A1 and MMP13. These expression patterns of iChon cells
were maintained after passaging them (Figure S3C).
The bisulfate sequencing analysis revealed that the cytosine
guanine (CpG) dinucleotides in the regulatory element of the
Induced Chondrogenic Cells from Human Fibroblasts
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fibroblast-marker gene COL1A1 were demethylated in human
iChon cells, whereas it was not methylated in the parental HDFs
(Figure 3C). These results suggest that the fibroblast marker gene,
COL1A1, was silenced during the induction of human iChon cells.
We next investigated the cartilage tissue-forming activities of
iChon cells by pellet culture. The histology of the pellet culture of
iChon cells showed cartilaginous structures (Figure 4A). The
matrix of the iChon pellet showed intense metachromatic toluidine
blue staining, whereas that of CD-hBMSC pellet looked fibrous.
The matrix was hardly formed in the HDF pellet. Picrosirius red
staining revealed the fibrous alignment of collagen fibers in CD-
hBMSC pellet and HDF pellet, but not in the iChon pellet under
polarized microscopic observations. These results suggest that the
matrix of the iChon pellet has a hyaline cartilaginous structure;
Figure 1. The generation and selection of induced chondrogenic (iChon) cells from human dermal fibroblast (HDF) culture. (A) Top,
a schematic diagram of the gene transduction. Middle left, HDFs. Middle right, polygonal-shaped cells generated by transduction of c-MYC, KLF4, and
SOX9. Bottom left, nodules formed by polygonal-shaped cells. Bottom right, nodules were intensely stained with alcian blue, suggesting the
production of glycosaminoglycan. Bars in top panels, 100 mm; Bars in bottom panels, 500 mm. (B) Top, a schematic diagram of the gene transduction.
Left middle and bottom panels, phase and GFP images of cell nodules formed in HDF culture at 18 days after transduction with c-MYC, KLF4 and
SOX9. Right middle and bottom panels, magnification of the boxed region in the left panels. Cells were cultured in the absence of puromycin Bars in
left panels, 500 mm; Bars in right panels, 100 mm. (C) HDF cultures which had been transduced with lentiviral COL11A2- reporter vectors and
nucleofected with Slc7a1 were transduced with retroviral c-MYC, KLF4 and SOX9, or DsRed fluorescent protein, or SOX5, SOX6 and SOX9. Cells were
cultured in the absence of puromycin. Dishes (10 cm in diameter) were stained with alcian blue 21 days after retroviral transduction. The numbers of
nodules with positive alcian blue staining were counted. (D) HDF cultures which had been transduced with lentiviral COL11A2- reporter vectors and
nucleofected with Slc7a1 were transduced with retroviral c-MYC, KLF4 and SOX9, or DsRed fluorescent protein, or SOX5, SOX6 and SOX9. Puromycin
was added to the medium 7 days after retroviral transduction. Dishes (10 cm in diameter) were stained with crystal violet and alcian blue 21 days
after retroviral transduction. The numbers of all colonies stained with crystal violet (white bars) and the numbers of colonies with positive alcian
staining (black bars) were counted. In (C and D), after nucleofection of Slc7a1, HDFs were replated at a density 56105 cells per 10 cm dish for
retroviral transduction. Cells were split 1:5 onto 10 cm dishes immediately after completion of the retroviral transductions. The numbers of nodules in
five 10 cm dishes which were derived from one identical dish were added together. Error bars indicate 6 SD (n= 3 dishes).
doi:10.1371/journal.pone.0077365.g001
Induced Chondrogenic Cells from Human Fibroblasts
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e77365
whereas the matrix of the CD-hBMSC pellet has a fibrocartilag-
inous structure. Immunohistochemistry showed that the matrix
contained type II collagen, but not type I collagen (Figures 4B and
4C). These results suggest that human iChon cells produce hyaline
cartilage in vitro.
The Origin of Induced Chondrogenic Cells in the HDF
Culture
To gain insight into the original cell type which gives rise to
chondrogenic cells in HDF culture, we performed time-lapse
observations of whole wells of a 6-well plate during the induction
of chondrogenic cells (Figure 5). COL11A2-GFP fluorescence was
not observed at 3 days after retroviral c-MYC, KLF4 and SOX9
transduction throughout the whole wells (Figure 5A, left panel).
Some cell clusters expressed COL11A2-GFP fluorescence at 8 days
after transduction (Figure 5A, second panel, arrowheads), and
gradually formed nodules, increasing the level of GFP fluores-
cence. At 14 days after transduction, some nodules (Figure 5A,
third panel, arrowheads) specifically expressed COL11A2-GFP,
while others did not. We retrospectively analyzed 23 nodules of
chondrogenic cells which expressed COL11A2-GFP and identified
their original cells at the start of induction. The cells of origin of all
23 nodules expressing COL11A2-GFP did not express GFP at the
start of the induction. A close examination revealed that the cells
Figure 2. The characteristics of human iChon cell lines. (A) Phase
images of human iChon cell lines and HDFs. The photos were taken
when the cell numbers had expanded and reached 107. Bar: 100 mm. (B)
The mRNA levels of cMYC, KLF4 and SOX9 in iChon cells. The relative
expression levels in comparison to human HDFs or HFCs are shown. The
mRNA levels were determined by a real-time RT-PCR analysis using
primers specific for endogenous transcripts (white columns) and those
common for both transgenic and endogenous transcripts (black
columns). The error bars indicate 6 SD (n= 3). (C) The growth curves
of human iChon cells and parental HDFs. (D) The karyotype of human
iChon cells. iChon cell line#87-18 was examined at passages 15. A total
of 20 cells for each cell line were examined. HDF, human dermal
fibroblasts; HFC, redifferentiated human fetal chondrocytes.
doi:10.1371/journal.pone.0077365.g002
Figure 3. Marker gene expression of human iChon cell lines.
RNA samples were extracted from iChon cells at passage 7. (A) The
quantitative expression analyses of chondrocyte and fibroblast marker
genes in human iChon cell lines, HDFs and HFC. Error bars indicate the
6 SD (n=3). *P,0.01 compared with iChon cell lines by Student’s t-
test. (B) The quantitative expression analyses of chondrocyte hypertro-
phy and terminal differentiation marker genes in human iChon cell
lines, HDFs and CD-hBMSCs. Error bars indicate the 6 SD (n= 3). The
relative expression levels of COL10A1 and MMP13 mRNAs were zero in
iChon cell lines. (C) Methylation of the regulartory region of the COL1A1
gene. Bisulfite genomic sequencing of the regulartory regions of
COL1A1 was performed using DNA derived from iChon cell lines and
HDFs. Each horizontal row of circles represents an individual
sequencing result from one amplicon. Open circles indicate unmethy-
lated CpG dinucleotides, while closed circles indicate methylated CpGs.
The nucleotide numbers for COL1A1 are indicated at the bottom. The
ATG translation initiation codon is set as +1 (GenBank accession
number NC 000017, nt 48261457). HDFs, human dermal fibroblasts;
HFC, redifferentiated human fetal chondrocytes; CD-hBMSCs, chondro-
genically differentiated human bone marrow stem cells.
doi:10.1371/journal.pone.0077365.g003
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from which the COL11A2-GFP-positive cells originated did not
express COL11A2-GFP one day after transduction with c-MYC,
KLF4 and SOX9, and only started to express COL11A2-GFP at 5–
7 days after transduction (Figures 5B and 5C, and Movies S1 and
S2). The mouse Col11a2 regulatory sequences which correspond to
the human COL11A2 promoter-enhancer used in the lentiviral
COL11A2-reporter gene direct the expression from prechondro-
genic cells during mesenchymal condensation [12,16].
In addition, we examined the proportions of cells expressing
SOX9 in HDF culture. SOX9 is known to be expressed in
chondroprogenitor cells [22]. Immunofluorescence staining of
parental HDFs with anti-SOX9 antibodies revealed that the
signals were at the background level in almost all cells (Figure S4).
The ratio of possible prechondrogenic cells indicated by immu-
noreactivity against anti-SOX9 antibody in the HDF culture
(0.019%, Figure S4C) was lower than the frequency of alcian blue-
positive cells generated from HDFs (0.24%, Figure 1D). A close
examination revealed that almost all SOX9-positive signals in the
Figure 4. Characterization of matrix of pellet culture of iChon
cells. The iChon cells at passage 7 were used. (A) After 3 weeks of
culture, pellets of iChon cells (# 117-3), chondrogenically differentiated
human bone bone marrow stem cells (CD-hBMSC), and human dermal
fibroblasts (HDFs) were recovered and processed for histological
sections. Semiserial sections were stained with toluidine blue and
picrosirius red. Sections stained with picrosirius red were observed
under polarized microscopy. Bars in the top and third rows, 500 mm;
Bars in the second and bottom rows, 50 mm. (B) Semiserial sections of
pellets of iChon cells (#117-37) after 3weeks of culture were stained
with toluidine blue, and immunostained with anti-type I collagen
antibodies and anti-type II collagen antibodies. Bars, 100 mm. (C)
Control for immunohistological analysis in (B). Histological sections
from osteochondroma samples dissected at a time of surgery were
immunostained with anti-type I collagen and anti-type II collagen
antibodies. Panels are magnification of boxed regions in Figure S7. Bar,
100 mm. C, cartilage; B, bone.
doi:10.1371/journal.pone.0077365.g004
Figure 5. The origins of iChon cells in HDF culture. HDFs were
transduced with the lentiviral COL11A2-reporter vector, nucleofected
with Slc7a1, and transduced with retroviral c-MYC, KLF4 and SOX9
vectors. Cells were replated onto a well of a 6 well plate immediately
after completion of the retroviral transduction. The well was cultured in
the absence of puromycin and subjected to time-lapse GFP observation
using the Biostation CT (Nikon). (A) The entire wells were each scanned
using a total of 64 images (8 rows68 columns), and a tiled image was
reconstituted. The time-lapse GFP fluorescence of the tiled images at 3,
8 and 14 days after transduction of retroviral c-MYC, KLF4 and SOX9
vectors (3 left panels), and a phase contrast image 14 days after
transduction (right panel), spanning an entire well of a 6 well plate are
shown. GFP fluorescence was not observed at 3 days after retroviral
transduction. Some cell clusters expressed COL11A2-GFP fluorescence at
8 days after transduction (arrowheads), and gradually formed nodules,
increasing the level of GFP fluorescence. At 14 days after transduction,
some nodules (arrowheads) specifically expressed COL11A2-GFP and
others did not. Bar, 10 mm. (B) The magnification of the boxed regions
in (A). At 1 day after transduction, no cells expressed COL11A2-GFP,
suggesting that they were not chondrogenic cells. A cluster of cells with
polygonal morphology started to express COL11A2-GFP weakly (arrow)
at 5 days after transduction. The cells in the cluster increased in number
and expressed COL11A2-GFP (half-arrow) at 7 days after transduction. A
cell cluster formed multiple layers, forming a nodule which expressed
COL11A2-GFP strongly at 14 days after transduction. These results
suggest that iChon cells are derived from non-chondrogenic cells which
did not express COL11A2-GFP. Bar, 100 mm. (C) Magnification of the
boxed regions in (B). GFP images were enhanced to detect weak
fluorescent signals. Only the polygonal cell clusters expressed COL11A2-
GFP, but the surrounding fibroblast cells did not express COL11A2-GFP.
Bar, 50 mm.
doi:10.1371/journal.pone.0077365.g005
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HDF culture were false-positive signals, because the signals were
on the edge of cells or debris and did not localize in in the nucleus.
These results collectively suggest that non-chondrogenic cells were
the major source of the iChon cells.
Hyaline Cartilage Formation by Human iChon Cells in the
Subcutaneous Spaces in Nude Mice
We next investigated the cartilage-forming activities of iChon
cells in vivo. We injected independent iChon cell lines suspended in
the medium into the subcutaneous spaces of nude mice (Table S1).
Four weeks after injection, we found solid nodules at 14 out of the
42 sites that were injected (33%). We found no nodule formation
in the other 28 sites. A histological analysis revealed that these
nodules contained cartilage-like tissue (Figure 6A). Cells were
scattered in the matrix, which was positively stained with safranin
O. We recognized that the cells resided in lacuna, which is
characteristic of cartilage histology. An immunohistochemical
analysis showed that the matrix contained type II collagen, but not
type I collagen, suggesting that the tissue formed by the injection
of human iChon cells was hyaline cartilage (Figure 6B). The cells
in the cartilage expressed human vimentin, indicating that the
injected iChon cells survived and formed cartilage. Longer-term
observation showed that the formed cartilage gradually disap-
peared from the subcutaneous spaces (Table S1). We found no
tumor formation at 76 injected sites, including 17 sites that were
observed for 3 months (Table S1).
Cartilaginous Tissue Formation by Human iChon Cells in
the Articular Cartilage Defects Created in the SCID Rat
We further examined whether iChon cells form cartilage in
orthotopic sites. We implanted human iChon cells into defects
created in the articular cartilage of six knees of SCID rats. Four
weeks after implantation, the defects were partially filled with
cartilaginous tissue in four out of the six knees (Figure 6C). The
cartilaginous tissues showed positive immunostaining for type II
collagen. The expression of type X collagen was below the limit of
detection. Immunostaining for human vimentin showed that the
cartilaginous tissue was composed of human cells. The human
iChon cell-derived cartilaginous tissue was surrounded by scar
tissue which consisted of host cells. These results suggest that
human iChon cells survive and form cartilaginous tissue in the
articular cartilage defects for at least four weeks.
The Low Susceptibility of Human iChon Cells to
Osteogenic Conditions
We examined how iChon cells respond to osteogenic conditions.
Human iChon cells did not express the OSTEOCALCIN gene
(BGLAP) or RUNX2 gene when they were cultured in the
osteogenic medium containing 100 ng/ml BMP2 for 21 days,
although expression of the OSTERIX gene (SP7) and the alkaline
phosphatase gene (ALPL) were slightly increased by the addition of
BMP2 (Figure 7A). The SP7 and ALPL genes were expressed in
chondrocytes as well as osteoblasts.
Human iChon cells produced cartilaginous tissue and did not
form bone, when implanted into the defects created in the calvaria
of SCID mice (Figure 7B). The calvarial defects were healed
spontaneously, and found to be filled with host bone tissue. These
results collectively suggest that human iChon cells did not respond
to osteogenic conditions.
Discussion
Although small articular cartilage defects measuring less than
2 cm2 in size can be treated with autologous chondrocyte
transplantation, the treatment of larger cartilage defects remains
a challenge. Cell reprogramming techniques have the potential to
resolve this problem by providing a sufficient number of hyaline
chondrocytes to fill large defects. In this study, we generated
human iChon cells directly from HDF culture by transduction of
two reprogramming factors (c-MYC and KLF4) and one
chondrogenic factor (SOX9). Human iChon cells were generated
from non-chondrogenic cells in HDFs, as indicated by the lack of
COL11A2 promoter/enhancer activities and the fact that the
majority of the cells had no endogenous SOX9 expression.
Human iChon cells generated hyaline cartilage without tumor
formation in the subcutaneous space of nude mice. Human iChon
cells also formed cartilage in the defects of articular cartilage and
did not respond to osteogenic conditions. These results suggest
that human iChon cells can be a candidate cell source for
regenerative medicine to treat articular cartilage diseases.
It was previously reported that a high level of overexpression of
SOX5, SOX6 and SOX9 could activate the expression of
chondrocyte-markers in HDFs using adenoviral vectors [11],
although fibroblastic characteristics appeared to be remained. We
found that the retroviral transduction of c-MYC, KLF4, and
SOX9 following Slc7a1 nucleofection produced substantial num-
bers of cartilaginous nodules in HDF culture, whereas retroviral
transduction of SOX5, SOX6 and SOX9 following Slc7a1
nucleofection did not. These results indicate that the reprogram-
ming factors c-MYC and KLF4 more efficiently contribute to the
SOX9-induced conversion of fibroblasts into chondrogenic cells
than SOX5 and SOX6. c-Myc and Klf4 are responsible for
erasing the characteristics of fibroblasts during iPS cell induction
by c-Myc, Klf4, Oct3/4 and Sox2 [23]. The expression of
fibroblast markers was observed to decrease first, followed by an
increase in the expression of chondrocyte markers during the
induction of mouse chondrogenic cells from MDFs by c-Myc, Klf4
and SOX9 [14]. These findings suggest that c-MYC and KLF4
are involved in epigenetic events in HDFs, and enable SOX9 to
direct cells to the chondrogenic lineage during the induction of
iChon cells.
The c-MYC, KLF4, and SOX9 transgenes were not silenced in
human iChon cells. The silencing of retroviral transgenes is a
phenomenon that is a characteristic of pluripotent cells [24]
including iPS cells [15]. Retroviral transgenes are not usually
silenced in somatic cells and somatic cells which are produced by
direct conversion technique [12,25,26]. Human iChon cells
expressed neither type X collagen nor MMP13. Human iChon
cells retain their chondrogenic phenotype after being passaged in
monolayer culture. These results suggest that human iChon cells
therefore stay in hyaline chondrocytes and do not undergo
hypertrophy. This characteristic of human iChon cells is favorable
when considering their application to cell transplantation for the
potential treatment of defects of articular cartilage which consists
of hyaline cartilage and seldom undergo hypertrophy. CD-
hBMSCs tend to undergo hypertrophy and thus can be lost
quickly after cell transplantation [27]. Human iChon cells do not
undergo hypertrophy, probably because of their continued
expression of the SOX9 transgene.
Cell type conversion through iPS cells is associated with two
different risks of tumor formation: one is the risk of teratoma
formation associated with the pluripotency of iPS cells [28], and
the other is associated with the transduction of the reprogramming
factors [13]. The iChon cells are theoretically free from the former
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risk, because mouse iChon cells do not enter a pluripotent state
during induction, as indicated by the lack of Nanog-GFP
expression during induction [14]. However, iChon cells are
obviously still associated with the latter risk, because c-MYC and
KLF4 are used, although the human iChon cells did not produce
tumors for at least 3 months after being injected into nude mice.
Safer iPS cells have recently been generated by using integration-
free vectors such as episomal plasmid vectors [29] and Sendi virus
vectors [30]. Because persistent transgene expression is not
necessary for the maintenance of mouse iChon cells as long as
they are cultured in a chondrogenic medium containing TGF-b
and BMPs [12], it will be ideal to generate human iChon cells by
transient expression of c-MYC and KLF4 using integration-free
vectors, to minimize the risk of tumor formation. The persistent
expression of the SOX9 transgene may positively contribute to the
stable chondrogenic phenotype of iChon cells without undergoing
hypertrophy in this study. If iChon cells are generated by the
transient expression of c-MYC, KLF4 and SOX9, such iChon
cells would undergo hypertrophy in a manner similar to that of
CD-hBMSCs. An engineered cartilage using CD-hBMSCs
undergo hypertrophy faster than articular cartilage and thus can
be lost quickly after cell transplantation [27]. However, the
constitutive expression of Sox9 can be of another concern, because
all tissues undergo remodeling in vivo, and an engineered cartilage
that does not respond to physiological regulation may present
long-term challenges. Further study will thus be needed to
stringently control the hypertrophy of such iChon cells during
cartilage repair.
Human iChon cells differ from mouse induced chondrogenic
cells in several aspects. The karyotypes of the majority of human
iChon cells were normal, whereas the karyotypes are fairly
unstable in mouse iChon cells [12]. Human iChon cell lines did
Figure 6. In vivo cartilage formation by human iChon cells in the subcutaneous spaces of nude mice (A and B) and articular cartilage
defects created in SCID rat (C). The iChon cells at passage 7 were used. Mice were sacrificed at 4 weeks after subcutaneous injection of iChon
cells, and nodules at the injected sites were collected. Rats were sacrificed 4 weeks after implantation. (A) The histological features of nodules formed
by injected iChon cells into subcutaneous spaces of nude mice. Safranin O-fast green-iron hematoxylin staining. Cartilaginous matrix was specifically
stained with Safranin O as an orange color. Bars in top panels, 500 mm; Bars in bottom panels, 100 mm. (B) The expression of differentiation-related
proteins in nodules formed by injected iChon cells into subcutaneous spaces of nude mice. Semiserial sections of nodules derived from injected 87-
18 human iChon cell were stained with Safranin O-fast green-iron hematoxylin and immunostained with anti-type I collagen, anti-type II collagen and
anti-human vimentin antibodies. The bars in top panels, 500 mm; in bottom panels, 100 mm. (C) Human iChon cells (line#117-3) were implanted into
defects created in the articular cartilage of the distal femurs of SCID rats. Four weeks after implantation the rats were sacrificed. Semiserial sections
were stained with hematoxylin-eosin and immunostained with anti-type II collagen, anti-type X collagen, and anti-human vimentin antibodies.
Brackets indicate regions of defects created in the articular cartilage. The bars, 100 mm.
doi:10.1371/journal.pone.0077365.g006
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not form tumors when transplanted into nude mice, whereas
inappropriately reprogrammed mouse induced chondrogenic cells
developed into tumors [12]. A possible reason for the more stable
karyotypes and non-tumorigenicity of human iChon cells is related
to the limited proliferative activities of human iChon cells, whereas
mouse induced chondrogenic cells appear to have almost
unlimited proliferative potential [12].
Stable karyotypes and non-tumorigenicity are favorable char-
acteristics of human iChon cells when considering their applica-
tion to regenerative medicine. Although various obstacles remain,
human iChon cells can contribute to the development of cell
sources to generate hyaline cartilage-related biomaterials.
Supporting Information
Figure S1 The lentiviral COL11A2- reporter vector. (A) A
schematic representation of the lentiviral vectors carrying EGFP-
IRES-Puro linked to the COL11A2 promoter plus the COL11A2
enhancer. (B) Left, EGFP expression in human dermal fibroblasts
(HDFs) and human chondrosarcoma (HCS-2/8) cells transduced
with the lentiviral COL11A2-reporter vector. Bars, 100 mm. Right,
the results of a flow cytometric analysis of the EGFP expression
from the reporter vectors in the cells.
(JPG)
Figure S2 An immunoblot analysis of the expression of
SOX5, SOX6 and SOX9 retroviral vectors in HDF
culture. The Plat-E cells were transfected with pMXs-SOX5,
pMXs-SOX6, pMXs-SOX9 and pMXs-EGFP. Supernatants
containing each of the retroviruses were added to the HDFs that
had been nucleofected with Slc7a1. The cells were lysed 7 days
after retroviral transduction, and then were subjected to an
immunoblot analysis using anti-SOX5, anti-SOX6 and anti-
SOX9 antibodies (Supplementary Table S4) as indicated on the
left of membranes (top row). Membranes were reprobed with anti-
b-actin antibodies (bottom row).
(JPG)
Figure S3 The presence of transgenes in iChon cells,
karyotypes of iChon cells, and marker gene expression
in iChon cells after passage numbers. (A) The presence of
transgenes in iChon cells. PCR reactions were performed with
template genomic DNA extracted from each iChon cell line using
primers specific for each transgene. GAPDH was used as a
control. HDF, human dermal fibroblasts. (B) The karyotypes of
human iChon cells. iChon cell lines #117-3 and #117-37 were
examined at passages 18 and 22, respectively. A total of 20 cells for
each cell line were examined. (C) The results of an analysis of
marker gene expression in iChon cell lines (#89-9 and #117-37)
after various passage numbers. P9, passage 9; P11, passage 11;
P13, passage 13. The expression levels of chondrocyte markers
were maintained, and the expression of fibroblast markers was
maintained at low levels, after all of the passage numbers
examined. Error bars indicate the 6 SD (n= 3 dishes). HDFs,
human neonatal dermal fibroblasts; HFCs, redifferentiated human
fetal chondrocytes.
Figure 7. The response of human iChon cells to osteogenic conditions. (A) Human iChon cells (line #117-37) were cultured in the
osteogenic medium (a-MEM supplemented with 10% FBS, 10 mM b-glycerophosphate, 50 mg/ml ascorbic acid, and 1027 M dexamethasone with the
absence or presence of various concentrations of BMP2 as indicated at the bottom of the graphs) for 21 days. RNAs were extracted and subjected to a
real-time RT-PCR expression analysis. Error bars indicate the6 SD (n= 3). (B) Human iChon cells were implanted into defects created in the calvaria of
SCID mice. Three weeks after implantation, the mice were sacrificed. Semiserial sections were stained with hematoxylin-eosin and safranin O, and
immunostained with anti-human vimentin antibodies. The magnification of boxed regions in the left panel is shown in the right three panels,
respectively. The bars in the left panels, 250 mm; in the other panels, 50 mm.
doi:10.1371/journal.pone.0077365.g007
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(JPG)
Figure S4 The frequencies of prechondrogenic cells in
HDF cultures. (A) Immunofluorescence staining of human
dermal fibroblasts (HDF) in one well of a 6 well plate with anti-
SOX9 antibodies. The nuclei were stained with PI. Each whole
well was scanned as an 868 image, and the tiling images were
reconstituted using the Biostation CT (Nikon). Top left, a tiling
image of SOX9 immunofluorescence. Bottom left, magnification
of the boxed region in the top left panel. Phase images (top right)
and nuclear stained images with PI (bottom right) corresponding
to the bottom left panel. Bars in the top left panels, 10 mm; bars in
the bottom left, top right and bottom right panels, 100 mm. (B) As
a positive control for SOX9 immunofluorescence, mouse induced
chondrogenic MK-7 cells (Hiramatsu, et al., J Clin Invest 121(2):
640-57) were used. Bar, 100 mm. (C) The frequencies of cells
showing immunoreactivity against anti-Sox9 antibodies in HDF
culture. The cell numbers were counted with the CL-Quant
software program (Nikon). Three wells of a 6-well plate were
analyzed. The positive cell numbers represent the numbers of cells
showing immunofluorescence (Alexa Fluor) with anti-Sox9
antibodies.
(JPG)
Figure S5 Controls for the immunohistochemical anal-
ysis. Histological sections from osteochondroma samples dissect-
ed at a time of surgery were immunostained with anti-type I
collagen and anti-type II collagen antibodies under the conditions
used in this study. The hyaline cartilage of the cartilage cap
(arrows) showed immunoreactivity against the anti-type II collagen
antibody, but did not show immunoreactivity against the anti-type
I collagen antibody. Magnification of boxed regions are shown in
Figure 4C. Bar, 1 mm.
(JPG)
Table S1 The results of the subcutaneous injection of
human iChon cell lines into nude mice.
(DOC)
Table S2 The sequences of the primers used for the
transgenes.
(DOC)
Table S3 The sequences of primers for the marker
genes, bisulfite sequencing, and PCR cloning.
(DOC)
Table S4 The antibodies used for the experiments.
(DOC)
Movie S1 Time-lapse images taken during the induc-
tion of iChon cells. HDFs were transduced with the lentiviral
COL11A2 reporter vector, nucleofected with Slc7a1, and trans-
duced with retroviral c-MYC, KLF4 and SOX9 vectors. Cells
were replated onto a well of a 6 well plate immediately after
completion of the retroviral transduction. The well was cultured in
the absence of puromycin and subjected to time-lapse GFP
observation using the Biostation CT program (Nikon). Phase
(Movie S1) and GFP (Movie S2) images were captured every 8 h
for 14 consecutive days. Each image is shown for 0.5 sec, thus 8 h
corresponds to 0.5 sec.
(AVI)
Movie S2 Time-lapse images taken during the induc-
tion of iChon cells. HDFs were transduced with the lentiviral
COL11A2 reporter vector, nucleofected with Slc7a1, and trans-
duced with retroviral c-MYC, KLF4 and SOX9 vectors. Cells
were replated onto a well of a 6 well plate immediately after
completion of the retroviral transduction. The well was cultured in
the absence of puromycin and subjected to time-lapse GFP
observation using the Biostation CT program (Nikon). Phase
(Movie S1) and GFP (Movie S2) images were captured every 8 h
for 14 consecutive days. Each image is shown for 0.5 sec, thus 8 h
corresponds to 0.5 sec.
(AVI)
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